通过 Vericiguat 进行验证
Luong Nguyen1, Danial E Baker1
1Washington State University, Spokane, WA, USA.
Hospital pharmacy
|September 15, 2023
概括
单式专著服务为药学和治疗委员会提供每月的药物专著,帮助药物评估和利用. 订阅者可以在线访问这些可定制的资源和药物使用评估.
科学领域:
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 药品和治疗 (P&T) 委员会需要及时,基于证据的药物信息来做出配方决定.
- 评估新的和新兴的药物疗法对于优化药物使用和患者结果至关重要.
- 获取全面的药物专著和利用评估支持了知情的临床实践.
研究的目的:
- 描述表单式专著服务的内容和功能.
- 突出医疗保健专业人员参与药物管理的服务价值.
- 告知潜在订阅者关于月刊专著更新和药物使用评估的好处.
主要方法:
- 该服务每月提供5-6篇关于新药或晚期试验药物的详细专著.
- 为药房和护理服务和日程提供一页的摘要专著.
- 包括综合药物利用评估/药物使用评估 (DUE/MUE) 的研究.
主要成果:
- 订阅者会获得与临床实践相关的持续更新的药物信息.
- 专著可以在线访问,提供方便和灵活性.
- 定制选项允许设施根据特定需求定制内容.
结论:
- 单式专著服务支持P&T委员会和医疗保健专业人员提供关键药物信息.
- 该服务促进了知情的表单管理和药物使用评估.
- 在线访问和可定制的功能提高了提供的药物专著的实用性.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
197
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
197
Antihypertensive Drugs: Angiotensin II Receptor Blockers
776
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
776
Heart Failure Drugs: Diuretics
418
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
418
Antihypertensive Drugs: Direct Renin Inhibitors
677
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
677
Antihypertensive Drugs: Potassium-Sparing Diuretics
628
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
628
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
183
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
183


